|
Class I and class II discrepancies |
|||
| N |
|||
|
|
|||
| Opportunistic |
VRE pneumonia |
2 |
|
| infections |
Legionella pneumonia |
1 |
|
| (n = 10) |
PCP pneumonia |
1 |
|
| Invasive aspergillosis |
1 |
||
| Candida empyema |
1 |
||
| Class I |
VZV meningoencephalitis |
1 |
|
| discrepancies |
HSV esophagitis |
1 |
|
| (n = 15) |
CMV pneumonia |
1 |
|
| Disseminated necrotizing toxoplasmosis |
1 |
||
|
|
|||
| Cardiac |
Ischemic cardiomyopathy |
2 |
|
| complications |
Thrombotic endocarditis |
2 |
|
| (n = 5) |
|||
| Congestive heart failure |
1 |
||
|
|
|||
| Cardiopulmonary |
Pulmonary embolism |
4 |
|
| Class II |
complications |
||
| discrepancies |
(n = 7) |
Thrombotic endocarditis |
2 |
| (n = 10) |
Pulmonary hemorrhage |
1 |
|
|
|
|||
| Opportunistic |
Candidemia |
1 |
|
| infections (n = 3) |
VRE meningitis |
1 |
|
| CMV proctitis |
1 |
||
|
CMV, cytomegalovirus; HSV, herpes simplex virus; PCP, pneumocystis carinii pneumonia; VRE, vancomycin-resistant enterococcus; VZV, varicella-zoster virus. | |||
Pastores et al. Critical Care 2007 11:R48 doi:10.1186/cc5782 |
|||